课题基金 / 基金详情

COMPARISON SOFTWARE TO ASSESS NGS ACCURACY & BOOST TRANSLATIONAL RESEARCH

COMPARISON SOFTWARE TO ASSESS NGS ACCURACY & BOOST TRANSLATIONAL RESEARCH
评估 NGS 准确性的比较软件
批准号:
10081512
负责人:
Xing Xu
金额:
$25.17万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2021-06-30

项目摘要

项目成果

Xing Xu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary SolveBio is a cloud-based data platform for biopharma clinical and translational research. The goal of this project is to implement a graphical user interface-based comparison software suite to flexibly compare next generation sequencing (NGS) results for patients across replicates, assays, commercial vendors, biospecimens, and timepoints, with an initial application in assessing liquid biopsy accuracy. Liquid biopsy is an emerging non-invasive method for screening and monitoring actionable mutations but technological and biological hurdles remain. Comparing and evaluating NGS data generated by different assays is difficult to impossible for most individual scientists. Solving this challenge has the potential to catalyze progress in the adoption of precision oncology and facilitate the broader application of next-generation sequencing technologies to provide more efficient clinical care to patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Variant Explorer: a cloud-based data integration and visualization system for improving clinical interpretation of sequenced genetic variants.
  • 批准号:
    9045271
  • 项目类别:
  • 资助金额:
    $22.32万
  • 财政年份:
    2016
  • 负责人:
    Xing Xu
  • 依托单位:
海外基金